Dr. Agarwal's Health Care Limited (BOM:544350)
India flag India · Delayed Price · Currency is INR
497.20
+13.80 (2.85%)
At close: Jul 13, 2026

Dr. Agarwal's Health Care Statistics

Total Valuation

BOM:544350 has a market cap or net worth of INR 152.64 billion. The enterprise value is 161.43 billion.

Market Cap152.64B
Enterprise Value 161.43B

Important Dates

The next estimated earnings date is Monday, August 3, 2026.

Earnings Date Aug 3, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 316.98M
Shares Outstanding n/a
Shares Change (YoY) +6.27%
Shares Change (QoQ) +0.61%
Owned by Insiders (%) 28.95%
Owned by Institutions (%) 11.41%
Float 60.42M

Valuation Ratios

The trailing PE ratio is 114.61 and the forward PE ratio is 82.53.

PE Ratio 114.61
Forward PE 82.53
PS Ratio 7.34
PB Ratio 7.20
P/TBV Ratio 17.49
P/FCF Ratio 214.87
P/OCF Ratio 29.41
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.34, with an EV/FCF ratio of 227.24.

EV / Earnings 121.20
EV / Sales 7.76
EV / EBITDA 28.34
EV / EBIT 55.03
EV / FCF 227.24

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.50.

Current Ratio 1.24
Quick Ratio 0.96
Debt / Equity 0.50
Debt / EBITDA 1.87
Debt / FCF 15.01
Interest Coverage 3.24

Financial Efficiency

Return on equity (ROE) is 8.31% and return on invested capital (ROIC) is 7.20%.

Return on Equity (ROE) 8.31%
Return on Assets (ROA) 4.82%
Return on Invested Capital (ROIC) 7.20%
Return on Capital Employed (ROCE) 8.43%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count 4,214
Asset Turnover 0.55
Inventory Turnover 13.26

Taxes

In the past 12 months, BOM:544350 has paid 805.00 million in taxes.

Income Tax 805.00M
Effective Tax Rate 32.38%

Stock Price Statistics

The stock price has increased by +11.76% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +11.76%
50-Day Moving Average 463.44
200-Day Moving Average 473.60
Relative Strength Index (RSI) 59.81
Average Volume (20 Days) 5,620

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:544350 had revenue of INR 20.80 billion and earned 1.33 billion in profits. Earnings per share was 4.18.

Revenue20.80B
Gross Profit 9.24B
Operating Income 2.93B
Pretax Income 2.49B
Net Income 1.33B
EBITDA 5.70B
EBIT 2.93B
Earnings Per Share (EPS) 4.18
Full Income Statement

Balance Sheet

The company has 2.82 billion in cash and 10.66 billion in debt, with a net cash position of -7.85 billion.

Cash & Cash Equivalents 2.82B
Total Debt 10.66B
Net Cash -7.85B
Net Cash Per Share n/a
Equity (Book Value) 21.20B
Book Value Per Share 63.76
Working Capital 1.11B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.19 billion and capital expenditures -4.48 billion, giving a free cash flow of 710.40 million.

Operating Cash Flow 5.19B
Capital Expenditures -4.48B
Depreciation & Amortization 2.76B
Net Borrowing -2.23B
Free Cash Flow 710.40M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 44.44%, with operating and profit margins of 14.10% and 6.40%.

Gross Margin 44.44%
Operating Margin 14.10%
Pretax Margin 11.95%
Profit Margin 6.40%
EBITDA Margin 27.38%
EBIT Margin 14.10%
FCF Margin 3.42%

Dividends & Yields

BOM:544350 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 0.82%
Buyback Yield -6.27%
Shareholder Yield -6.27%
Earnings Yield 0.87%
FCF Yield 0.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Analyst Forecast

The average price target for BOM:544350 is 545.00, which is 9.61% higher than the current price. The consensus rating is "Buy".

Price Target 545.00
Price Target Difference 9.61%
Analyst Consensus Buy
Analyst Count 5
Revenue Growth Forecast (3Y) 20.45%
EPS Growth Forecast (3Y) 40.44%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 7